Suganuma Yuka, Takahashi Hiroshi, Nishimura Rimei
Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8 Nishishimbashi, Minato-ku, Tokyo, 105-8461 Japan.
Diabetol Int. 2022 May 23;13(4):672-678. doi: 10.1007/s13340-022-00585-y. eCollection 2022 Oct.
To investigate glycemic excursions and changes in time in hypoglycemia (hyT) in Japanese type 1 diabetes (T1D) patients 2 months after the first initiation of intermittently scanned continuous glucose monitoring (isCGM).
We enrolled 15 adult T1D patients on insulin therapy to evaluate changes in the parameters for glycemic excursions 2 months after initiating isCGM by using the Wilcoxon signed-rank test. Binomial logistic regression analyses were also used to identify predictors of hypoglycemia.
A total of 14 patients were available for analysis. Median HbA1c decreased significantly from 7.6% (interquartile range, 6.9-8.3%) to 7.2% (6.7-7.8%) ( = 0.047). Mean glucose, standard deviation of glucose, time in range, and time above range were not significantly different from baseline, while time below range (from 2.2 [1.0-6.9] to 5.0 [2.0-10.8]%; = 0.016), hyT (from 26.8 [14.5-75.5] to 56.8 [21.7-110.9] min/day; = 0.030), and time in severe hypoglycemia (shT, from 4.3 [0.0-8.9] to 11.0 [0.0-24.3] min/day; = 0.022) increased significantly. Additionally, shT increased significantly only during daytime. The factor associated with hyT was found to be the reduction in total insulin dose after 2 months.
In T1D patients with a median HbA1c of 7.6%, HbA1c was significantly decreased 2 months after initiating isCGM, while hyT increased, particularly during daytime. Study results suggest that a reduction in the total insulin dose of about 0.10 U/kg may be required in some cases. These findings need to be taken into account when initiating isCGM.
The online version contains supplementary material available at 10.1007/s13340-022-00585-y.
调查日本1型糖尿病(T1D)患者首次开始间歇性扫描式动态血糖监测(isCGM)2个月后的血糖波动及低血糖时间(hyT)变化。
我们纳入了15名接受胰岛素治疗的成年T1D患者,通过Wilcoxon符号秩检验评估开始isCGM 2个月后血糖波动参数的变化。还采用二项逻辑回归分析来确定低血糖的预测因素。
共有14名患者可供分析。HbA1c中位数从7.6%(四分位间距,6.9 - 8.3%)显著降至7.2%(6.7 - 7.8%)(P = 0.047)。平均血糖、血糖标准差、血糖达标时间及血糖高于目标范围时间与基线相比无显著差异,而血糖低于目标范围时间(从2.2 [1.0 - 6.9]%增至5.0 [2.0 - 10.8]%;P = 0.016)、hyT(从26.8 [14.5 - 75.5]分钟/天增至56.8 [21.7 - 110.9]分钟/天;P = 0.030)及严重低血糖时间(shT,从4.3 [0.0 - 8.9]分钟/天增至11.0 [0.0 - 24.3]分钟/天;P = 0.022)显著增加。此外,仅在白天shT显著增加。发现与hyT相关的因素是2个月后总胰岛素剂量的减少。
在HbA1c中位数为7.6%的T1D患者中,开始isCGM 2个月后HbA1c显著降低,而hyT增加,尤其是在白天。研究结果表明,某些情况下可能需要将总胰岛素剂量降低约0.10 U/kg。开始isCGM时需要考虑这些发现。
在线版本包含可在10.1007/s13340 - 022 - 00585 - y获取的补充材料。